Results 161 to 170 of about 63,090 (300)

Crowd psychology and the politics of co‐production: Social control, democratic order and the consequences of theory

British Journal of Social Psychology, Volume 65, Issue 2, April 2026.
Abstract Social psychology has long claimed neutrality in its explanations of collective behaviour, yet its foundational theories of crowds have repeatedly been co‐produced with institutions of authority and mobilized in the reactionary governance of social order.
Clifford Stott
wiley   +1 more source

A Randomized Controlled Trial of Hypnosis to Manage Musculoskeletal Pain in Breast Cancer Survivors Taking Aromatase Inhibitors. [PDF]

Psychol Conscious (Wash D C)
Montgomery GH, Schnur JB, Tiersten A, Benck K, Erblich J.   +4 more
europepmc   +1 more source

Alpha‐2‐adrenoreceptor agonists as analgesic drugs in equine medicine

Equine Veterinary Education, Volume 38, Issue 4, Page 220-228, April 2026.
Summary Managing pain in horses is challenging despite the availability of nonsteroidal anti‐inflammatory drugs, local anaesthetics, opioids and α2‐adrenoreceptor agonists. While α2‐agonists are widely used for sedation and restraint, their analgesic properties remain underutilised.
J. A. E. Hubbell, J. Brandly, W. W. Muir III, J. Page, K. Hopster   +4 more
wiley   +1 more source

Using virtual reality hypnosis during stem cell transplant for patients in hematology: A protocol for a feasibility randomized study. [PDF]

PLoS One
Laurin A, Rousseaux F, Fournier V, Roy J, Landry M, LeBlanc R, Godin N, Arbour C, Richebé P, Jerbi K, Rainville P, Ogez D.   +11 more
europepmc   +1 more source

Perspectives on Time and Personality: Philip G. Zimbardo (1934–2024) in Memoriam

Journal of Personality, Volume 94, Issue 2, Page 181-198, April 2026.
ABSTRACT The present paper aims to honor the memory of one of the most notable figures in psychological science over the past five decades, Philip G. Zimbardo, who sadly passed away in late 2024. To this end, we provide a multi‐perspective view on psychological time—a topic that deeply engaged Phil Zimbardo during the later stages of his prolific ...
Maciej Stolarski, Thomas Suddendorf, Marc Wittmann, Daphna Oyserman, Jeff Joireman, Kalman Victor, Yaacov Trope, Gerald Matthews   +7 more
wiley   +1 more source

Hypnosis as an Adjunct to Topical Anesthesia for Awake Intubation in a Patient With Difficult Airway: A Case Report. [PDF]

Case Rep Anesthesiol
Torlakovic S, Grandjean-Progin C, Nikles F, Stiennon O.   +3 more
europepmc   +1 more source

The Effects of Daridorexant on Patients With Comorbid Insomnia Disorder and Untreated Mild Obstructive Sleep Apnoea: A Post Hoc Subgroup Analysis of a Phase 3, Randomised Clinical Trial

Journal of Sleep Research, Volume 35, Issue 2, April 2026.
ABSTRACT Daridorexant, a dual orexin receptor antagonist, is approved for the treatment of insomnia disorder in adults. Approximately 30%–35% of patients with insomnia disorder also have obstructive sleep apnoea (OSA) of any severity. It is unclear whether sleep medications provide safe and effective treatment for insomnia in these patients.
Christopher J. Lettieri, Orestis Briasoulis, Damien Léger, Pierre‐Philippe Luyet, Jean‐Louis Pépin, Stuart F. Quan, Janna Raphelson, Paul Saskin, Atul Malhotra   +8 more
wiley   +1 more source

Effect of hypnosis on psychological distress in female university students with premenstrual syndrome. [PDF]

Discov Ment Health
Heydarpour S, Heydarpour F, Dehghan F, Torabi Y.   +3 more
europepmc   +1 more source

Methylphenidate and (lis)dexamfetamine toxicity‐related deaths of adults, Australia, 2000–24: analysis of NCIS data

Medical Journal of Australia, Volume 222, Issue 5, Page 259-261, March 2025.
Shane Darke, Amy Peacock, Johan A Duflou, Michael Farrell, Julia Lappin   +4 more
wiley   +1 more source

Management of Insomnia Complaints by Non‐Sleep Specialist Physicians: A French DELPHI Consensus

Journal of Sleep Research, Volume 35, Issue 2, April 2026.
ABSTRACT Insomnia is the most prevalent sleep disorder and a major public health concern, affecting chronically up to 19% of the adult population in France. Despite its significant impact on quality of life, mental health, and cardiometabolic disease, insomnia disorder remains underdiagnosed and inadequately managed.
Pierre‐Alexis Geoffroy, Jean‐Louis Pépin, Marjorie Guillet, Jean‐Bastien Micoulaud‐Franchi, Yves Dauvilliers, Damien Léger, Sylvie Royant‐Parola   +6 more
wiley   +1 more source